Donnell Alison J, Pliskin Neil, Holdnack James, Axelrod Bradley, Randolph Christopher
Department of Psychiatry, University of Illinois at Chicago, Chicago, IL, USA.
Arch Clin Neuropsychol. 2007 Nov;22(8):917-24. doi: 10.1016/j.acn.2007.06.007. Epub 2007 Jul 27.
Although the Wechsler Full Scale IQ (FSIQ) is a common component of most neuropsychological evaluations, there are many clinical situations where the complete administration of this battery is precluded by various constraints, including limitations of time and patient compliance. These constraints are particularly true for dementia evaluations involving elderly patients. The present study reports data on two short forms particularly suited to dementia evaluations, each requiring less than 20min of administration time. One of the short forms was previously validated in dementia for the WAIS-R [Randolph, C., Mohr, E., & Chase, T. N. (1993). Assessment of intellectual function in dementing disorders: Validity of WAIS-R short forms for patients with Alzheimer's, Huntington's, and Parkinson's disease. Journal of Clinical and Experimental Neuropsychology, 15, 743-753]; the second was developed specifically for patients with motor disabilities. These short forms were validated using the WAIS-III normative standardization sample (N=2450), neurologic sample (N=63), and matched controls (N=49), and a separate mixed clinical sample (N=70). The results suggest that each short form provides an accurate and reliable estimate of WAIS-III FSIQ, validating their use in appropriate clinical contexts. The present data support the use of these short forms for dementia evaluations, and suggests that they may be applicable for the evaluation of other neurological and neuropsychiatric disorders that involve acquired neurocognitive impairment.
尽管韦氏全量表智商(FSIQ)是大多数神经心理学评估中的常见组成部分,但在许多临床情况下,由于各种限制因素,包括时间限制和患者配合度等,无法完整实施该测试组合。这些限制在涉及老年患者的痴呆症评估中尤为突出。本研究报告了两种特别适用于痴呆症评估的简短形式的数据,每种形式的施测时间均少于20分钟。其中一种简短形式先前已在痴呆症患者中针对韦氏成人智力量表修订版(WAIS-R)进行了验证[伦道夫,C.,莫尔,E.,&蔡斯,T.N.(1993年)。痴呆症患者智力功能评估:WAIS-R简短形式对阿尔茨海默病、亨廷顿舞蹈病和帕金森病患者的有效性。《临床与实验神经心理学杂志》,15,743 - 753];第二种是专门为有运动障碍的患者开发的。这些简短形式使用韦氏成人智力量表第三版(WAIS-III)的常模标准化样本(N = 2450)、神经科样本(N = 63)和匹配对照组(N = 49)以及一个单独的混合临床样本(N = 70)进行了验证。结果表明,每种简短形式都能对WAIS-III FSIQ提供准确可靠的估计,验证了它们在适当临床环境中的应用。目前的数据支持将这些简短形式用于痴呆症评估,并表明它们可能适用于评估其他涉及获得性神经认知障碍 的神经和神经精神疾病。